Mostrar el registro sencillo del ítem

dc.contributor.authorCalvo Martínez, Lourdes 
dc.date.accessioned2017-06-07T07:00:02Z
dc.date.available2017-06-07T07:00:02Z
dc.date.issued2013
dc.identifier.issn0732-183X
dc.identifier.urihttp://hdl.handle.net/20.500.11940/1518
dc.language.isoeng
dc.titleFluorouracil, Doxorubicin, and Cyclophosphamide (FAC) Versus FAC Followed by Weekly Paclitaxel As Adjuvant Therapy for High-Risk, Node-Negative Breast Cancer: Results From the GEICAM/2003-02 Study
dc.typeArtigoes
dc.authorsophosMartin, M.
dc.authorsophosRuiz, A.
dc.authorsophosBorrego, M. R.
dc.authorsophosBarnadas, A.
dc.authorsophosGonzalez, S.
dc.authorsophosCalvo, L.
dc.authorsophosVila, M. M.
dc.authorsophosAnton, A.
dc.authorsophosRodriguez-Lescure, A.
dc.authorsophosSegui-Palmer, M. A.
dc.authorsophosMunoz-Mateu, M.
dc.authorsophosRibugent, J. D.
dc.authorsophosLopez-Vega, J. M.
dc.authorsophosJara, C.
dc.authorsophosEspinosa, E.
dc.authorsophosFernandez, C. M.
dc.authorsophosAndres, R.
dc.authorsophosRibelles, N.
dc.authorsophosPlazaola, A.
dc.authorsophosSanchez-Rovira, P.
dc.authorsophosBofill, J. S.
dc.authorsophosCrespo, C.
dc.authorsophosCarabantes, F. J.
dc.authorsophosServitja, S.
dc.authorsophosChacon, J. I.
dc.authorsophosRodriguez, C. A.
dc.authorsophosHernando, B.
dc.authorsophosAlvarez, I.
dc.authorsophosCarrasco, E.
dc.authorsophosLluch, A.
dc.identifier.doi10.1200/jco.2012.46.9841
dc.identifier.isi330537800029
dc.identifier.pmid23733779
dc.identifier.sophos11693
dc.issue.number20
dc.journal.titleJournal Of Clinical Oncology
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario A Coruña::Oncoloxía médica
dc.page.initial2593-+
dc.rights.accessRightsopenAccess
dc.typesophosArtículo Original
dc.volume.number31


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem